Answers are grounded in this paper and cite their sources.
Background Bacterial meningitis remains a public health concern, yet countries in Central America lack published national epidemiological descriptions. Methods In a retrospective population-based study, ICD-10 -coded national hospital discharge and mortality databases from Honduras (2014 -2024) and reference-laboratory surveillance data (INCIENSA/SIREVA II) from Costa Rica were analyzed. Crude rates per 100,000 inhabitants and standardized discharge ratios (SDR) were calculated. Age-specific discharge rates were computed using population census denominators. Results Honduras registered 1,345 hospital discharges and 236 deaths directly attributed to bacterial meningitis. The discharge rate peaked in 2016 (1.98/100,000) and dropped markedly during the COVID-19 pandemic (0.80/100,000 in 2020), showing partial recovery by 2024 (1.09/100,000). Most cases occurred in adults (median age 38 years; male-to-female ratio 1.27:1). Four departments showed an SDR significantly above 1. Notably, 75.3% ( n = 1,013) of hospital discharges were coded as unspecified bacterial meningitis (G00.9), and 19.1% as tuberculous meningitis (A17.0), highlighting a critical laboratory confirmation deficit. In contrast, Costa Rica’s reference laboratory characterized 199 culture-confirmed invasive isolates: Streptococcus pneumoniae predominated (62.3%, 38 distinct serotypes), followed by Neisseria meningitidis [21.6%, with serogroup B (55.8%) and Y (30.2%) predominant] and Haemophilus influenzae (16.1%). Conclusion This first subregional profile reveals major surveillance gaps; stronger diagnostic stewardship and integrated molecular surveillance are urgently required to close them and to guide vaccination strategy, in line with the targets of the WHO Global Roadmap to Defeat Meningitis by 2030.
No takes yet. Share an insight, caveat, or question.
Salgado et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: